Investing RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202 by admin June 4, 2025 June 4, 2025 Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202 Download the PDF here. This post appeared first on investingnews.com previous post 5 Biggest Blockchain ETFs in 2025 next post Adam Rozencwajg: Gold Stock Gains, Silver and Uranium Prices — Plus PGMs Bull Case You may also like Valeura Ranked No. 1 of Canada’s Top Growing... October 3, 2025 Q1 2025 Management’s Discussion and Analysis May 14, 2025 Bold Ventures Closes $776,800 Non-Brokered Private Placement January 3, 2026 Tech Weekly: Micron Rises on Latest Results, Trump... December 21, 2025 Biggest Canadian Defense Contractors and ETFs in 2025 July 17, 2025 CEO Appointment May 19, 2025 Domestic Metals: Investing in America’s Copper Future to... February 26, 2026 Crypto Market Recap: Bitcoin Price Hits New All-time... May 22, 2025 Crypto Market Recap: Bitcoin Breaks US$111,000, Trump Courts... May 24, 2025 Appendix 4E August 29, 2025